Amiodarone in cardiac arrhythmias

[proceedings of a symposium held at Guy"s Hospital, London, on 27th October 1978 sponsored by Reckitt-Labaz] ; edited by W. T. Simpson and A. D. S. Caldwell.

Publisher: Royal Society of Medicine, Publisher: Grune and Stratton in London, New York

Written in English
Published: Pages: 72 Downloads: 908
Share This


  • Amiodarone -- Congresses.,
  • Arrhythmia -- Chemotherapy -- Congresses.

Edition Notes

Includes bibliographies.

SeriesInternational congress and symposium series - Royal Society of Medicine -- no. 16, International congress and symposium series -- no. 16.
ContributionsCaldwell, A. D. S., Simpson, Wilfrid Tord.
LC ClassificationsRC685.A65 A45, RC685A65 A45
The Physical Object
Paginationviii, 72 p. :
Number of Pages72
ID Numbers
Open LibraryOL22359642M
ISBN 100808912291, 0127940839

Ventricular arrhythmias occur commonly following myocardial infarction and carry important prognostic implications. The mechanisms involved are varied and time‐dependent, changing with the evolution of the infarct, and this has implications for the management of both the arrhythmia and the index ischemic insult, which are discussed in this by: 4.   Background. Sudden cardiac death (SCD) is an important cause of death nowadays. People at high risk (mainly with any sort of heart disease) die unexpectedly from cardiac causes, primarily from arrhythmia (an irregular heartbeat). The treatment of choice is a device called an implantable cardiac defibrillator (ICD), but it is not widely available in low- or middle-income countries. Amiodarone is used worldwide to treat cardiac arrhythmias, as well as highly symptomatic cases of atrial fibrillation. With this expanded use, especially following its United States Food and Drug Administration approval, and its use as a long-term therapy in common practice, reports of. Background: Amiodarone and acupuncture (AA) are commonly used to treat cardiac arrhythmia (CA). The objective of this systematic review is to assess the efficacy and safety of AA for patients with CA.

Arrhythmias are common after cardiac surgery such as coronary artery bypass grafting surgery. Although most of these arrhythmias are transient and have a benign course, it may represent a significant source of morbidity and mortality. Postoperative arrhythmias (POAs) include atrial tachyarrhythmias, ventricular arrhythmias, and : Bandar Al-Ghamdi. Introduction. A basic knowledge of the cardiac action potential and cardiac conduction system facilitates understanding of cardiac arrhythmias. The effects and side-effects of anti-arrhythmic drugs are depended on the influence on ion channels involved in the generation and/or perpetuation of the cardiac .   Cardiac Arrhythmia PDF 1. Seminar on Cardiac Arrhythmia and its treatment Submitted by Souvik Pal Roll No: Reg. No: S_ID: B , 3rd Year, 6th Semester Netaji Subhas Chandra Bose Institute of Pharmacy Tatla, Roypara, Chakdaha, Dist-Nadia, Pin- Affiliated to Maulana Abul Kalam Azad University of Technology BF, Sector 1, . The most commonly prescribed AAD is now amiodarone. This drug is effective in terminating and preventing a wide variety of symptomatic supraventricular and ventricular arrhythmias. However, amiodarone is plagued by frequent side effects and requires close monitoring. The most concerning toxicity is pulmonary fibrosis.

Drug cabinet: Anti-arrhythmics Some abnormal heart rhythms can be treated with medication. Consultant cardiologist and electrophysiologist Dr Martin Lowe explains all to Doireann Maddock. An arrhythmia is an abnormal heart rhythm and it happens as a result of a problem with the electrical impulses that regulate your heart. It can make your.

Amiodarone in cardiac arrhythmias Download PDF EPUB FB2

Amiodarone in Cardiac Arrhythmias (International congress and symposium series / Royal Society of Medicine) [W.T. Simpson] on *FREE* shipping on qualifying offers. Amiodarone in Cardiac Arrhythmias (International congress and symposium series / Royal Society of Medicine): W.T.

Simpson: : Books. Amiodarone in cardiac arrhythmias. London: Royal Society of Medicine ; New York: Grune & Stratton, (OCoLC) Material Type: Conference publication: Document Type: Book: All Authors / Contributors: A D S Caldwell; W T Simpson; Royal Society of.

It is used to help keep the heart beating normally in people with life-threatening heart rhythm disorders of the ventricles (the lower chambers Amiodarone in cardiac arrhythmias book the heart that allow blood to flow out of the heart).

Amiodarone is used to treat ventricular tachycardia or ventricular fibrillation.5/ amiodarone with placebo that reported the incidence of supraven-tricular arrhythmia, atrial fibrillation, or atrial flutter as the primary end point.

Data Extraction: Two investigators independently collected all data. Discrepancies were resolved by consensus.

Data Synthesis: After File Size: KB. apy. Monitor heart rate and rhythm throughout therapy; PR prolonga-tion,slightQRSwidening,T-waveamplitudereductionwithT-wavewid-eningandbifurcation,ongationmaybe associated with worsening of arrhythmias and should be monitored closely during IV therapy.

Report bradycardia or increase in arrhyth-File Size: KB. User Reviews for Amiodarone to treat Arrhythmia. Also known as: Pacerone, Nexterone. The following information is NOT intended to endorse drugs or recommend therapy. While these reviews might be helpful, they are not a substitute for the expertise, skill, knowledge and judgement of healthcare practitioners in patient care/ Can be useful to control heart rate in patients with atrial fibrillation when other measures are unsuccessful or contraindicated.

Heart Rate Control. Cardioversion: 5 to 7 mg/kg IV over 30 to 60 minutes, then to g per day continuous IV or divided oral doses until 10 g total 1. mg IV over 10 min, then to 1 mg/min 2. Within ACLS, amiodarone is used for its antiarrhythmic properties and is effective for the treatment of supraventricular arrhythmias and Amiodarone in cardiac arrhythmias book arrhythmias.

The mechanism of action for amiodarone’s antiarrhythmic properties remains unclear, but it continues to be the primary antiarrhythmic medication for the treatment of ventricular fibrillation and ventricular tachycardia within the cardiac arrest algorithm.

Amiodarone (pacerone & nexterone) is a medication formulated to improve heartbeat rhythm. Doctors prescribe the drug to patients with life-threatening ventricle-related heart rhythm disorders to ensure the heart beats normally. The ventricles are the heart’s lower chambers that allow blood flow out from the heart.

Amiodarone is an antiarrhythmic medication used to treat and prevent a number of types of irregular heartbeats. This includes ventricular tachycardia (VT), ventricular fibrillation (VF), and wide complex tachycardia, as well as atrial fibrillation and paroxysmal supraventricular tachycardia.

Evidence in cardiac arrest, however, is poor. It can be given by mouth, intravenously, or ncy category: AU: C, US: D (Evidence of risk). Amiodarone is used worldwide to treat cardiac arrhythmias, as well as highly symptomatic cases of atrial fibrillation.

With this expanded use, especially following its United States Food and Drug Administration approval, and its use as a long-term therapy in common practice, reports of cancers temporarily related to amiodarone have begun to by: 2.

Amiodarone is recommended for shock-refractory ventricular arrhythmia during resuscitation; however, it is unknown whether amiodarone is effective for preventing ventricular arrhythmia recurrence in out-of-hospital cardiac arrest (OHCA) survivors treated with targeted temperature management (TTM).Cited by: 1.

Amiodarone as an iodinated benzofuran derivative is a potent antiarrhythmic drug that is being used for the treatment of a wide variety of cardiac arrhythmias.

For the first time, the Russian physiologist, Gleb Von Anrep discovered the original precursor molecule of Amiodarone that was called : Fereshteh Mehraein. Neonatal Cardiac Arrhythmias INTRODUCTION: Identification and treatment of arrhythmias in newborns is challenging and differs from older children, and the natural history of arrhythmias presenting in the neonatal period is often dramatically different.

METHODS OF DIAGNOSIS AND THERAPY: For management of arrhythmias, consult Cardiology team. Medication Classification. Amiodarone is classified as an antiarrhythmic drug, meaning that it is used on patients who have heart arrhythmias especially atrial flutter, atrial fibrillation, and tachyarrhythmias.

The most common arrhythmia that we use this medication on. Amiodarone is very effective for the treatment of atrial arrhythmias, especially atrial fibrillation. In the CTAF study, amiodarone was more effective at maintaining sinus rhythm than sotalol or propafenone.

72 This was also echoed by findings from the SAFE-T trial, which compared amiodarone to sotalol or a. Amiodarone in the prevention and treatment of arrhythmia. Auer J(1), Berent R, Eber B. Author information: (1)2nd Medical Department, General Hospital Wels, Austria. @ There is good evidence that amiodarone is effective against a variety of arrhythmias and that it may be superior to other drugs in some by: Amiodarone is an antidysrhythmic used to terminate reentrant atrial or ventricular arrhythmias and has been a recurrent part the Advanced Cardiac Life Support (ACLS) algorithms.

It undergoes hepatic metabolism through cytochrome oxidase systems to produce another pharmacologically active but less potent metabolite, desethylamiodarone. The Role of Intravenous Amiodarone in the Management of Cardiac Arrhythmias Annals of Internal Medicine; (4): Amiodarone: Reevaluation of an Old Drug.

be effective in children with cardiac arrhythmias'; amiodarone resulted in either complete control (60%) or clinical improvement (/').1 The oral dosage and plasma concentrations of amiodarone associated with arrhythmia suppression in children havenot beenpreviously reported.

The unwanted effects experienced by adults receiving treatment with Cited by: Amiodarone is an iodinated benzofuran derivative that was synthesized and tested as an antianginal agent in the s but was later discovered to have antiarrhythmic properties.

Amiodarone is widely prescribed, largely due to its efficacy in the management of both supraventricular and ventricular arrhythmias. Amiodarone was initially developed in the early s as a treatment for angina pectoris, since it produces coronary vasodilation and decreases cardiac oxygen demand.

However, its pronounced antiarrhythmic effects redirected its use and amiodarone has become a widely used class III anti-arrhythmic drug. Compared to other antiarrhythmic drugs, it is more effective in treating both Cited by: Inthe American Heart Association recommended amiodarone as the primary antiarrhythmic agent for persistent ventricular tachycardia or ventricular fibrillation.[10].

Amiodarone is used to treat life-threatening heart rhythm problems called ventricular arrhythmias. This medicine is used in patients who have already been treated with other medicines that did not work well.

Amiodarone belongs to the group of medicines known as antiarrhythmics. It works directly on the heart tissue and will slow the nerve. The clinical uses of amiodarone, including recommendations for its use in the treatment of various arrhythmias, are discussed separately.

(See "Amiodarone: Clinical uses" and "Antiarrhythmic drugs to maintain sinus rhythm in patients with atrial fibrillation: Recommendations" and "Supportive data for advanced cardiac life support in adults with. Catheter Ablation of Cardiac Arrhythmias E-book.

by Shoei K. Stephen Huang and Mark A. Wood. out of 5 stars 4. Kindle $ $ 54 to rent $ to buy. Hardcover Electrophysiological Foundations of Cardiac Arrhythmias: A Bridge Between Basic Mechanisms and Clinical Electrophysiology. by Andrew L. Cardiac Arrhythmias John A Kastor,University of Maryland, Baltimore, Maryland, USA ine,amiodarone,b-adrenergicblockingagents,calciumchannelantagonistsand of sudden cardiac death due to a potentially fatal Cardiac Size: KB.

Amiodarone in the prevention and treatment of arrhythmia Article Literature Review in Current opinion in investigational drugs (London, England: ) 3(7) August with 45 Reads.

Abstract. Continuous ECG monitoring is a useful method to evaluate the efficacy of antiarrhythmic drugs. The aim of our study was to evaluate the effects of amiodarone ( mg day −1 for seven days and then mg day −1, five days a week, for 60 days) in 20 patients with chronic ischaemic heart disease ascertained by stress test, thallium myocardial scintigraphy and coronary Cited by: 1.

Amiodarone is an oral and injectable drug that is used to correct abnormal rhythms of the heart. (It is an antiarrhythmic medication.) Although amiodarone has many side effects, some of which are severe and potentially fatal, it has been successful in treating many arrhythmias when other antiarrhythmic drugs have failed.

Amiodarone is considered a "broad spectrum" antiarrhythmic medication. Conversion to oral amiodarone after intravenous (IV) administration. Less than 1 week IV infusion: mg/day ; week IV infusion: mg/day ; Greater than 3 week IV infusion: mg/day; Pediatric.

Drug Resistant Refractory Cardiac Arrhythmias (Off-label) Oral. Therapy for arrhythmias involves analysis of the proarrhythmic and adverse side effects and the desired antiarrhythmic effects of a medication. In the past decade, data on the increased mortality rate noted with conventional antiarrhythmic drug therapy have prompted the reexamination of available therapies and investigation into new Cited by:   US Pharm.

;7:HSHS Ventricular arrhythmias are disturbances in cardiac impulse generation or conduction that occur below the level of the bundle of His, which separates the atrial and ventricular tissues. These dysrhythmias include premature ventricular contractions (PVCs), ventricular tachycardias (VTs), ventricular fibrillation (VF), and sudden cardiac death (SCD).